In Vitro Stem Cell Hemotoxicity Testing

 

HemoGenix® is the Industry Leader in Predictive In Vitro Stem Cell Hemotoxicity Testing

HemoGenix® was the first to develop and commercialize assay platforms to specifically detect and predict hemotoxicity for drug discovery and development and environmental testing. The following summaries show the assays HemoGenix® has developed for its contract research services and its assay kits products for toxicity testing.

CFO Platform Summary 

To view or download a larger version of this summary, click here.

 

Toxicity Platform Summary

To view or download a larger version of this summary, click here.

 

Download the Hemotoxicity Testing Brochure here.


 
At HemoGenix®, we specialize in in vitro stem cell hemotoxicity testing and have developed a number of validated assays that can predict various aspects of toxicity to the blood-forming system. We provide both a Full Contract Research Service and an extensive Assay Kit Product Line for this purpose.